This editorial argues that GLP-1 receptor agonists could substantially improve healthspan and reduce premature mortality in ...
Human studies consistently report gut microbiome differences in mild cognitive impairment and Alzheimer’s disease, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results